Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134925) titled 'Evaluation of the Efficacy and Safety of Remimazolam Combined with Etomidate In Pain-Free Gastrointestinal Endoscopy for Obese Patients' on Oct. 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Yongchuan Hospital of Chongqing Medical University
Condition:
Obesity patients face significantly higher anesthesia risks during painless gastrointestinal endoscopy compared to individuals of normal weight due to pathophysiological changes such as reduced lung capacity, difficult airway management, multiple comorbidities, and complex pharmacokinetics.
Intervention:
RE Group:Ramazolam (0.2 ...